DOI QR코드

DOI QR Code

Epidemiology, Virology, and Clinical Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2; Coronavirus Disease-19)

코로나바이러스감염증-19의 바이러스 (SARS-CoV-2) 특징, 전파 및 임상 양상

  • Park, Su Eun (Department of Pediatrics, Pusan National University Children's Hospital)
  • 박수은 (부산대학교 어린이병원 소아청소년과학교실)
  • Received : 2020.03.15
  • Accepted : 2020.03.28
  • Published : 2020.04.25

Abstract

A cluster of severe pneumonia of unknown etiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was isolated from lower respiratory tract sample as the causative agent. The current outbreak of infections with SARS-CoV-2 is termed coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO). COVID-19 rapidly spread into at least 114 countries and killed more than 4,000 people by March 11, 2020. WHO officially declared COVID-19 a pandemic on March 11, 2020. There have been 2 novel coronavirus outbreaks in the past 2 decades. The outbreak of severe acute respiratory syndrome (SARS) in 2002-2003 caused by SARS-CoV had a case fatality rate of around 10% (8,098 confirmed cases and 774 deaths), while Middle East respiratory syndrome (MERS) caused by MERS-CoV killed 858 people out of a total 2,499 confirmed cases between 2012 and 2019. The purpose of this review is to summarize known-to-date information about SARS-CoV-2, transmission of SARS-CoV-2, and clinical features of COVID-19.

2019년 12월에 중국 후베이성 우한시에서 원인 미상 폐렴이 무리 지어 발생하기 시작하였다. 환자의 하기도에서 이전에 알려지지 않은 새로운 코로나바이러스가 분리되었으며 severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)로 명명되었다. 세계보건기구는 SARS-CoV-2에 의한 질병을 코로나바이러스감염증-19(coronavirus disease 2019, COVID-19)로 명명하였다. 2020년 3월 11일에 COVID-19는 전세계 최소 114국으로 퍼졌으며 약 4,000명이 사망하여 세계보건기구는 COVID-19가 세계적 대유행임을 선언하였다. 지난 20년 동안 새로운 코로나바이러스에 의한 두 번의 유행이 있었다. 2002-2003년 중증급성호흡기증후군(severe acute respiratory syndrome, SARS) 유행 시에는 8,098명의 확진 환자와 774명의 사망자가 발생하였으며, 2012년에 사우디 아라비아에서 시작되어 현재까지 주로 아라비아 반도에서 발생하고 있는 중동호흡기증후군(Middle East respiratory syndrome, MERS)는 2019년까지 총 2,499명의 환자와 858명의 사망자를 발생시켰다. 본 종설의 목적은 2020년 3월 12일까지 알려진 SARS-CoV-2의 특징과 전파 양상 및 COVID-19의 임상 증상을 알아보고 SARS와 MERS와의 유사점 및 차이점에 대하여 간략하게 소개하는 것이다.

Keywords

References

  1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol 2020;92:401-2. https://doi.org/10.1002/jmv.25678
  2. World Health Organization. Novel coronavirus (2019-nCoV), situation report-1, 21 January 2020 [Internet]. Geneva: World Health Organization; 2020 [cited 2020 Mar 2]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf.
  3. GISAID Database. 2020 coronavirus [Internet]. Munich, Germany: GISAID Database; 2020 [cited 2020 Mar 20]. Available from: https://www.gisaid.org/CoV2020.
  4. Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol 2020;79:104212. https://doi.org/10.1016/j.meegid.2020.104212
  5. World Health Organization. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020 [Internet]. Geneva: World Health Organization; 2020 [cited 2020 Mar 12]. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020.
  6. Gralinski LE, Menachery VD. Return of the coronavirus: 2019-nCoV. Viruses 2020;12:135. https://doi.org/10.3390/v12020135
  7. Kim JY, Choe PG, Oh Y, Oh KJ, Kim J, Park SJ, et al. The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures. J Korean Med Sci 2020;35:e61. https://doi.org/10.3346/jkms.2020.35.e61
  8. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. Geneva: World Health Organization; 2020 [cited 2020 Mar 11]. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.
  9. Korea Centers for Disease Control and Prevention. Updates on COVID-19 in Republic of Korea (as of 12 March). Cheongju: Korea Centers for Disease Control and Prevention; 2020.
  10. American Academy of Pediatrics. Coronaviruses, including SARS and MERS. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red $Book^{(R)}$: 2018 Report of the Committee on Infectious Diseases. 31st ed. Itasca: American Academy of Pediatrics, 2018:297-301.
  11. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 [Internet]. Geneva: World Health Organization; 2004 [cited 2020 Apr 1]. Available from: https://www.who.int/csr/sars/country/table2004_04_21/en/.
  12. Lee JS. Severe acute respiratory syndrome (SARS). In: Yoo JH, editor. Infectious disease. Seoul: Koonja, 2007:775-81.
  13. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012;367:1814-20. https://doi.org/10.1056/NEJMoa1211721
  14. Memish ZA, Perlman S, Van Kerkhove MD, Zumla A. Middle East respiratory syndrome. Lancet 2020;395:1063-77. https://doi.org/10.1016/s0140-6736(19)33221-0
  15. Oh MD, Park WB, Park SW, Choe PG, Bang JH, Song KH, et al. Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea. Korean J Intern Med 2018;33:233-46. https://doi.org/10.3904/kjim.2018.031
  16. Englund JA, Kim YJ, McIntosh K. Human coronaviruses, including Middle East respiratory syndrome coronavirus. In: Cherry J, Demmler-Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ, editors. Feigin and Cherry's textbook of pediatric infectious disease. 8th ed. Philadelphia: Elsevier Inc., 2019:1846-54.
  17. Brian DA, Baric RC. Coronavirus genome structure and replication. In: Enjuanes L, editor. Coronavirus replication and reverse genetics. Berlin: Springer, 2005:1-30.
  18. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727-33. https://doi.org/10.1056/NEJMoa2001017
  19. Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl), In press 2020.
  20. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020;395:514-23. https://doi.org/10.1016/s0140-6736(20)30154-9
  21. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536-44. https://doi.org/10.1038/s41564-020-0695-z
  22. Kan B, Wang M, Jing H, Xu H, Jiang X, Yan M, et al. Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms. J Virol 2005;79:11892-900. https://doi.org/10.1128/JVI.79.18.11892-11900.2005
  23. Lau SK, Woo PC, Li KS, Huang Y, Tsoi HW, Wong BH, et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci U S A 2005;102:14040-5. https://doi.org/10.1073/pnas.0506735102
  24. Anthony SJ, Gilardi K, Menachery VD, Goldstein T, Ssebide B, Mbabazi R, et al. Further evidence for bats as the evolutionary source of Middle East respiratory syndrome coronavirus. MBio 2017;8:e00373-17.
  25. Drosten C, Kellam P, Memish ZA. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med 2014;371:1359-60. https://doi.org/10.1056/NEJMc1409847
  26. Belouzard S, Millet JK, Licitra BN, Whittaker GR. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses 2012;4:1011-33. https://doi.org/10.3390/v4061011
  27. Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol 2020;5:562-9. https://doi.org/10.1038/s41564-020-0688-y
  28. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 2020;46:586-90. https://doi.org/10.1007/s00134-020-05985-9
  29. Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY, Loh J, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 2020;323:1488-94. https://doi.org/10.1001/jama.2020.3204
  30. To KK, Tsang OT, Chik-Yan Yip C, Chan KH, Wu TC, Chan JMC, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis, In press 2020.
  31. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382:1199-207. https://doi.org/10.1056/NEJMoa2001316
  32. Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA 2020;323:1610-2. https://doi.org/10.1001/jama.2020.3227
  33. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020;382:1564-7. https://doi.org/10.1056/NEJMc2004973
  34. Chan M. World now at the start of 2009 influenza pandemic [Internet]. Geneva: World Health Organization; 2009. Available from: https://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/.
  35. Liu Y, Gayle AA, Wilder-Smith A, Rocklov J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med 2020;27:taaa021. https://doi.org/10.1093/jtm/taaa021
  36. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020;382:1177-9. https://doi.org/10.1056/NEJMc2001737
  37. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA 2020;323:1406-7. https://doi.org/10.1001/jama.2020.2565
  38. Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol 2004;191:292-7. https://doi.org/10.1016/j.ajog.2003.11.019
  39. Jeong SY, Sung SI, Sung JH, Ahn SY, Kang ES, Chang YS, et al. MERS-CoV infection in a pregnant woman in Korea. J Korean Med Sci 2017;32:1717-20. https://doi.org/10.3346/jkms.2017.32.10.1717
  40. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020;395:809-15. https://doi.org/10.1016/s0140-6736(20)30360-3
  41. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. In press 2020.
  42. Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol, In press 2020.
  43. World Health Organization. Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19), 16-24 February 2020. Geneva: World Health Organization; 2020.
  44. Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. AJR Am J Roentgenol 2020;214:1072-7. https://doi.org/10.2214/AJR.20.22976
  45. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061. https://doi.org/10.1001/jama.2020.1585
  46. Chen J. Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes Infect 2020;22:69-71. https://doi.org/10.1016/j.micinf.2020.01.004
  47. Hui DS. Epidemic and emerging coronaviruses (severe acute respiratory syndrome and Middle East respiratory syndrome). Clin Chest Med 2017;38:71-86. https://doi.org/10.1016/j.ccm.2016.11.007

Cited by

  1. 국내 코로나바이러스감염증-19의 감염재생산수 추정 vol.48, pp.3, 2020, https://doi.org/10.7469/jksqm.2020.48.3.493
  2. COVID-19 and Progressive Orthodontics vol.54, pp.4, 2020, https://doi.org/10.1177/0301574220957539
  3. Risk Assessment of Importation and Local Transmission of COVID-19 in South Korea: Statistical Modeling Approach vol.7, pp.6, 2020, https://doi.org/10.2196/26784
  4. COVID-19 Vaccine Race: An Overview and Update vol.11, pp.2, 2020, https://doi.org/10.22270/jddt.v11i2.4752
  5. TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2 vol.25, pp.6, 2021, https://doi.org/10.1080/14728222.2021.1918103
  6. Preparedness of Young People for a Sustainable Lifestyle: Awareness and Willingness vol.13, pp.13, 2020, https://doi.org/10.3390/su13137204
  7. Skin Aging, Cellular Senescence and Natural Polyphenols vol.22, pp.23, 2020, https://doi.org/10.3390/ijms222312641